[Elsevier] Agonistic anti-CD40 antibody treatment converts resident regulatory T cells into activated type 1 effectors within the tumor microenvironment

pedrocunha Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-10-31 18:18
Reward10points

journalㄩImmunity

AuthorsㄩVivien I. Maltez; Charu Arora; Kyle P. Gribbin; Breanna Caruso; Margaret E. Haerr; Rina Sor; Qiaoshi Lian; Katie E. Blise; Shamilene Sivagnanam; Rosalie C. Sears; Lisa M. Coussens; Robert H. Vonderheide; Ronald N. Germain; Katelyn T. Byrne

Published dateㄩ2026-4-

DOIㄩ10.1016/j.immuni.2026.03.011

PDF linkㄩhttps://www.sciencedirect.com/sc ... 074761326001226/pdf

Article linkㄩhttps://doi.org/10.1016/j.immuni.2026.03.011

Article SourceㄩElsevier BV﹝


Remarkㄩ
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Senior Member
  • post

  • reply

  • points

    720


Daily Top Contributors

Return to the list